GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Overview Fund Activity
Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

164 hedge funds and large institutions have $2.2B invested in GW Pharmaceuticals Plc American Depositary Shares in 2016 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 53 increasing their positions, 33 reducing their positions, and 24 closing their positions.

Holders
164
Holders Change
+26
Holders Change %
+18.84%
% of All Funds
4.11%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
52
Increased
53
Reduced
33
Closed
24
Calls
$199M
Puts
$218M
Net Calls
-$19.1M
Net Calls Change
-$43.7M

Top Buyers

1
PP
1
Prudential plc
United Kingdom
$229M
2
O
2
OrbiMed
New York
$44.3M
3
SCM
3
Scopia Capital Management
New York
$233M
4
Goldman Sachs
4
Goldman Sachs
New York
$27.3M
5
Capital Fund Management (CFM)
5
Capital Fund Management (CFM)
France
$17M

Top Sellers

1
Bank of New York Mellon
1
Bank of New York Mellon
New York
$50.9M
2
RG
2
Redmile Group
California
$40.9M
3
Lord, Abbett & Co
3
Lord, Abbett & Co
New Jersey
$0
4
ACA
4
Avoro Capital Advisors
New York
$0
5
Capital World Investors
5
Capital World Investors
California
$71.1M
Name Market Value Shares Shares
Change 		Shares
Change %
Capital Research Global Investors
1
Capital Research Global Investors
California
$337M 3,017,604 – –
SCM
2
Scopia Capital Management
New York
$233M 2,084,567 +199,400 +11%
PP
3
Prudential plc
United Kingdom
$229M 2,050,212 +884,106 +76%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$192M 1,715,265 -39,593 -2%
DM
5
Deerfield Management
New York
$104M 928,192 -80,283 -8%
Viking Global Investors
6
Viking Global Investors
Connecticut
$102M 910,831 -71,824 -7%
Bank of America
7
Bank of America
North Carolina
$73.3M 656,291 -56,476 -8%
JHIU
8
Janus Henderson Investors US
Colorado
$72.8M 651,482 -123,271 -16%
Capital World Investors
9
Capital World Investors
California
$71.1M 635,800 -125,000 -16%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$52.2M 466,894 -74,720 -14%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$50.9M 455,827 -305,345 -40%
Franklin Resources
12
Franklin Resources
California
$49M 438,470 +14,300 +3%
O
13
OrbiMed
New York
$44.3M 396,600 +360,400 +996%
RG
14
Redmile Group
California
$40.9M 366,068 -179,854 -33%
RSCM
15
Rock Springs Capital Management
Maryland
$39.8M 356,000 +31,000 +10%
AllianceBernstein
16
AllianceBernstein
Tennessee
$30.6M 273,956 +20,589 +8%
BFA
17
BlackRock Fund Advisors
California
$29.5M 264,098 +56,824 +27%
Victory Capital Management
18
Victory Capital Management
Texas
$28.7M 256,387 +29,150 +13%
Morgan Stanley
19
Morgan Stanley
New York
$28.6M 256,361 +19,205 +8%
Millennium Management
20
Millennium Management
New York
$27.4M 244,980 +106,642 +77%
Goldman Sachs
21
Goldman Sachs
New York
$27.3M 243,882 +156,498 +179%
Federated Hermes
22
Federated Hermes
Pennsylvania
$27M 241,600 -46,080 -16%
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$20.1M 179,727 +89,619 +99%
Deutsche Bank
24
Deutsche Bank
Germany
$19.7M 176,527 +72,333 +69%
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$19.5M 174,499 +134,545 +337%
1
2 3 4 5